A vaccine is a biological production that offers the acquired immunity of a specific disease. Numerous vaccines are available in the market to treat conditions as per patients' needs. Due to stringent regulations and standards of the government, vaccine manufacturers are mandatory to follow the guidelines for vaccine development. Nowadays, the pharmaceutical and biopharmaceutical industries have been coming with advanced technologies in vaccine manufacturing.
MARKET DYNAMICS
Vaccine contract manufacturing market is anticipated to grow in the forecast period owing to driving factors such as capacity development by contract manufacturers for vaccine manufacturing, rise in vaccination coverage, and vaccination improvement and strong vaccine pipeline. Moreover, rising healthcare expenditure in emerging markets and cost & time saving profits offered by contract services are also offering opportunity in the market growth during the forecast period.
MARKET SCOPE
The "Global Vaccine Contract Manufacturing Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of vaccine contract manufacturing market with detailed market segmentation by vaccine type, workflow type, application, and geography. The global vaccine contract manufacturing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading vaccine contract manufacturing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global vaccine contract manufacturing market is segmented on the basis of vaccine type, workflow type, and application. Based on vaccine type, the vaccine contract manufacturing market is segmented as inactivated vaccines, attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines. Based on workflow type, the vaccine contract manufacturing market is segmented as downstream and upstream. Based on application, the market is segmented as human use and veterinary.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global vaccine contract manufacturing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The vaccine contract manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting vaccine contract manufacturing market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vaccine contract manufacturing market in these regions.
MARKET PLAYERS
The report covers key developments in the vaccine contract manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from vaccine contract manufacturing market are anticipated to lucrative growth opportunities in the future with the rising demand for vaccine contract manufacturing in the global market. Below mentioned is the list of few companies engaged in the vaccine contract manufacturing market.
The report also includes the profiles of key vaccine contract manufacturing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Lonza
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Merck KGaA
- AbbVie Inc.
- Cytovance Biologics
- Catalent, Inc.
- IDT Biologika
- ICON plc.
- Albany Molecular Research Inc. (AMRI)
- Charles River